The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation - Fruchart, Jean-Charles; Santos Filho, Raul Dias dos; Aguilar-salinas, Carlos; Aikawa, Masanori; Rasadi, Khalid Al; Amarenco, Pierre; Barter, Philip J; Ceska, Richard; Corsini, Alberto; Despres, Jean-Pierre (Cardiovascular diabetology, 2019)